10X Genomics Inc vs Vanguard Value Index Fund ETF — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Vanguard Value Index Fund ETF trades at $218.54. Which is the better fit depends on your goals.
| TXG | VTV | |
|---|---|---|
Market Cap | $5.48B | — |
Sector | Health | — |
52-Week High | $45.80 | $220.51 |
52-Week Low | $11.34 | $175.51 |
Enterprise Value | $5.02B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTV trades at $216.94, down 0.45% on the day, with a neutral technical signal and bullish moving averages. Recent news highlights its role as a stability-focused ETF amid AI sector volatility, with a 16% year-to-date gain. The fund's low expense ratio and value-oriented portfolio attract investors rotating away from tech.
The outlook for VTV hinges on continued value stock outperformance and Federal Reserve policy. Risks include inflation sensitivity and tech sector rebounds. Analyst sentiment is balanced, with the ETF positioned for defensive growth but vulnerable to macroeconomic shifts.
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →